Unlock instant, AI-driven research and patent intelligence for your innovation.

Polymer gene medicine carrier, preparation method thereof and use thereof for preparing antitumor medicine

A gene drug and polymer technology, applied in anti-tumor drugs, gene therapy, drug combination, etc., can solve safety problems and other problems, achieve the effect of good cancer cells and tumors, inhibition of cancer cells and tumors, and low toxicity

Inactive Publication Date: 2012-06-27
SUN YAT SEN UNIV
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, the use of siRNA to treat diseases needs to solve several problems: (1) Administration, that is, the introduction and orientation of siRNA, how to use high-efficiency vectors to deliver siRNA to target cells without affecting other unrelated cells, even including the release time (2) siRNA stability, including modification or embedding with delivery reagents to improve or control siRNA stability; (3) safety issues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polymer gene medicine carrier, preparation method thereof and use thereof for preparing antitumor medicine
  • Polymer gene medicine carrier, preparation method thereof and use thereof for preparing antitumor medicine
  • Polymer gene medicine carrier, preparation method thereof and use thereof for preparing antitumor medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Synthesis of macromolecule gene drug carrier targeting tumors with polyethylenimine as the backbone of hydroxypropyl cyclodextrin as branched chain folic acid:

[0033]

[0034] Dissolve 0.51g of hydroxypropyl cyclodextrin in 6ml of DMSO, add 0.1ml of triethylamine, and dissolve 0.42g of carbonyldiimidazole in 6ml, mix and stir for 1-3 hours under nitrogen protection in the dark. The product is hydroxypropyl cyclodextrin-carbonyldiimidazole. The product was added with 4° ether to produce a precipitate, which was filtered and dissolved in DMSO to form a hydroxypropyl cyclodextrin-carbonyldiimidazole DMSO solution. Dissolve 0.89g of polyethyleneimine with a molecular weight of 600 (CAS No. 9002-98-6) in DMSO, add the above hydroxypropyl cyclodextrin-carbonyldiimidazole DMSO solution dropwise, and place the mixture in a nitrogen-protected light-proof container Stirring was continued for 3-6 hours. The reacted product was placed in a dialysis bag with a molecular weigh...

Embodiment 2

[0037] Cytotoxicity tests and results of the compounds prepared in Example 1.

[0038] Cell lines and culture conditions: HepG2 (human liver cancer cells), Hela (human cervical cancer cells), HLF (human lung fibroblast-like cells), A549 (human lung cancer cells) were provided by the Experimental and Animal Center of Sun Yat-sen University. The cells were cultured in DMEM medium containing 10% fetal bovine serum, which contained 100 units of penicillin and 100 micrograms of streptomycin per milliliter, and the cells were seeded in a 10 cm diameter petri dish at 37 degrees, 5% CO 2 The cells were cultured in the environment, and passaged by trypsinization when the cells were confluent.

[0039] Cytotoxicity test: Cytotoxicity was measured by MTT method. The cells were digested with 0.25% trypsin into a single cell suspension, and the number of viable cells was calculated using a hemocytometer version, and the concentration of viable cells was adjusted to 5 × 10 4 Inoculate eac...

Embodiment 3

[0042] The polymer gene carrier prepared in Example 1 carried gene drug siRNA to inhibit tumor growth test and results.

[0043] Tumors were induced in nude mice first, and in order to obtain tumors, 50 μl of density was 10 6 HeLa cells were injected into 6-7 week old female nude mice with PBS solution. The tumor size was measured every day after the injection of cancer cells. The tumor size was measured with a vernier caliper. The length is (a) and the width is (b). The formula for calculating the tumor volume is V=0.5a×b 2 . When the tumor grows to 80mm 3 The administration was started at the beginning of time, and divided into four administration groups: (1) PBS as control; (2) no therapeutic effect siRNA / folate targeting carrier group; (3) treatment siRNA / no folic acid targeting carrier group; (4) treatment siRNA / folate targeting vector set. Administration was performed once every three days, and the administration method was tail vein injection, and each nude mouse w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a polymer material with cancer cell target and composite medicine carrying functions. With high medicine carrying efficiency, the easily synthesized polymer material can be used as a high-efficiency and low-toxicity gene medicine carrier to carry siRNA which can specifically silence a targeted cancer gene into cancer cells to inhibit the growth of cancer cells and tumors. Methyl thiazolyl tetrazolium (MTT) data indicate the cytotoxicity of the carrier is very low; flow cytometer and laser scanning confocal microscope data indicate the material has high anticancer siRNA carrying efficiency; and the results of WesternBolt and in-vivo experiments indicate the carrier has excellent cancer cell and tumor inhibiting effect in in-vitro and in-vivo experiments on specific silencing of cancer cells by carried gene medicine siRNA. In addition, because of simple preparation method, cheap raw materials and low synthesis cost, the carrier can be prepared in common chemical laboratory. The medicine carrier is a novel medicine carrier.

Description

technical field [0001] The invention relates to a polymer gene drug carrier and a preparation method thereof, in particular to a method for preparing a gene drug carrier with high efficiency and low toxicity by connecting a hydroxypropyl cyclodextrin-polyethyleneimine carrier skeleton with folic acid groups targeting tumors and its application in inhibiting tumor growth in nude mice. Background technique [0002] RNA interference (RNA interference, RNAi) refers to the phenomenon of efficient and specific degradation of homologous mRNA induced by double-stranded RNA (double-stranded RNA, dsRNA), which is highly conserved during evolution. Since the use of RNAi technology can specifically knock out or shut down the expression of specific genes, this technology has been widely used in the field of gene therapy for exploring gene functions and infectious diseases and malignant tumors. [0003] However, the use of siRNA to treat diseases needs to solve several problems: (1) Admi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/36A61K48/00C08G81/00C08G73/04C08B37/16A61P35/00
Inventor 毛宗万黎锦明黄华珍计亮年
Owner SUN YAT SEN UNIV